OneSource margin rebounds to 17.71% as expenses fall sequentially
Standalone revenue grew 39.08% YoY, but the margin remained below the Healthcare peer median and interest rose 37.17% QoQ.
Filed 24 Jul 2026, 19:03 IST · after market close · OneSource Specialty Pharma Ltd (ONESOURCE)
Key takeaways
- Standalone operating margin rose 7.75 percentage points QoQ to 17.71% as revenue grew 6.57% while expenses fell 2.61%.
- Revenue increased 39.08% YoY and operating profit grew 53.48%, lifting net profit 106.41% despite interest rising 12.91%.
- The 17.71% margin remained 6.93 percentage points below the 24.64% Healthcare peer median across 8 reported companies.
Price around the results
Q1FY27 earnings recovered from the weak December quarter
OneSource reported standalone revenue growth of 6.57% QoQ and 39.08% YoY, while operating profit increased 89.57% QoQ and 53.48% YoY. Net profit rose 138.5% QoQ and 106.41% YoY, with EPS reaching Rs 4.47. The results were filed after market close, so there is no immediate market reaction to assess.
Lower sequential costs drove the margin rebound
QoQ expenses fell 2.61% even as revenue grew 6.57%, widening operating margin by 7.75 percentage points. On a YoY basis, revenue grew 39.08% versus expense growth of 36.33%, producing a 1.66 percentage-point margin improvement. Interest rose 37.17% QoQ, partly offsetting the operating recovery, while other income contributed 7.4% of profit before tax and the tax rate was 0%.
Margin has improved for two straight quarters but trails peers
Operating margin moved from -5.2% in Q3FY26 to 9.96% in Q4FY26 and 17.71% in Q1FY27, marking two consecutive quarters of improvement. Even after the recovery, OneSource had the second-lowest margin among the 8 Healthcare companies that had reported, at 6.93 percentage points below the 24.64% sector median.
Past result-day moves have usually been negative
Across the last 7 results, the stock fell after 5 and rose after 2, with a median absolute move of 1.92%. The historical pattern has therefore been more often negative than positive, although the current filing came after market close and has no reported reaction yet.
Q1FY27 at a glance
Standalone figures as filed with NSE — cross-checked against an independent source.
| Line item | Q1FY27 | Q4FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹446 cr | ₹419 cr | +6.57% | +39.08% |
| Other income | ₹4 cr | ₹2 cr | +81.34% | -27.81% |
| Expenses | ₹367 cr | ₹377 cr | -2.61% | +36.33% |
| Operating profit | ₹79 cr | ₹42 cr | +89.57% | +53.48% |
| Operating margin (%) | 17.71% | 9.96% | — | — |
| Interest | ₹31 cr | ₹22 cr | +37.17% | +12.91% |
| Depreciation | ₹36 cr | ₹35 cr | +4.15% | +8.71% |
| Profit before tax | ₹51 cr | ₹21 cr | +138.50% | +106.41% |
| Tax | ₹0 cr | ₹0 cr | — | — |
| Net profit | ₹51 cr | ₹21 cr | +138.50% | +106.41% |
| EPS (₹) | ₹4.47 | ₹1.87 | +139.04% | +105.99% |
Operating margin of 17.71% compares with a Healthcare sector median of 24.64% across 8 peers that have reported Q1FY27.
What to watch
- Whether standalone operating margin holds above 17.71% after two consecutive quarterly improvements.
- Whether interest growth moderates from 37.17% QoQ.
- Whether revenue growth remains above 39.08% YoY.